ETAP-Lab - Preclinical Efficacy CRO
Ahmad ALLOUCHE is an experienced biologist currently serving as the Head of in vitro Biology at ETAP-Lab since February 2019. Prior to this role, Ahmad ALLOUCHE was the Head of Biology at SynAging SAS from January 2014 to August 2018, where expertise was applied in contract research with a focus on disease relevance and cost-effective services. Ahmad ALLOUCHE has also worked as a Project Leader at the University of Lorraine and completed a PhD as a student at Lipidomix from 2008 to 2012, investigating the effects of various food products on the well-being of aging individuals. Ahmad ALLOUCHE holds a PhD in Neuroscience/Nutrition from Universite de Lorraine, a Master 2 in Bio-processes, Agro-food, Nutrition, and Toxicology from Institut national polytechnique de Lorraine, a Postgraduate Diploma in Animal Biology, and a Bachelor of Science in Biological Sciences/Biochemistry from the University of Damascus.
This person is not in any teams
ETAP-Lab - Preclinical Efficacy CRO
ETAP-Lab provides preclinical models and services in the fields of Dermatology, Stroke and Neurodegenerative Diseases. The company has strong expertise in the field of Dermatology research and offers a large portfolio of original in vivo rodent models such as chronic skin inflammation, ischemic ulceration, psoriasis, hyperkeratosis, wound healing, atopic dermatitis, actinic keratosis, skin cancer… ETAP-Lab is also leader in the field of preclinical stroke research with a unique model portfolio consisting of innovative and translational models proposed under the brand Strok@lliance. With more than 2 decades of experience, ETAP-Lab has become a best-in-class service provider for top tier Pharma, Medical device and Agri-food companies and obtained ISO9001:v2015 certification for all its preclinical services. ETAP-Lab is listening to the needs of their clients to offer the most suited solution for products evaluation. Thus, its team is able to develop and customize relevant animal models with high translational value that fit to specific goals, from the proof-of-concept to the early development. Feel free to contact us!